Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clover Health Investments Corp (NQ: CLOV )

3.360 +0.010 (+0.30%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments Corp

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
46 Stocks Moving In Monday's Mid-Day Session
Gainers Houston American Energy Corp. (NYSE: HUSA) jumped 137.4% to $4.5150 amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc. (NASDAQ:... 
Via Benzinga
Insiders Buying These 4 Penny Stocks
US crude oil futures surged to their strongest levels since 2008 early this morning, amid the risk of Western ban on Russia’s oil imports. Investors, meanwhile, focused on some notable insider trades 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers TherapeuticsMD (NASDAQ:TXMD) stock increased by 56.5% to $0.33 during Monday's pre-market session. The company's market cap stands at $139.7 million.... 
Via Benzinga
Expert Ratings For Clover Health Investments
Within the last quarter, Clover Health Investments (NASDAQ:CLOV) has observed the following analyst ratings: 
Via Benzinga
Here’s the One Thing That Could Make or Break Clover Health Stock
Clover Health and CLOV stock rest in the hands of its direct contracting (DC) business. A new model could hinder or help its business. 
Via InvestorPlace
Benzinga's Daily Brief On Trending Tickers For March 3, 2022: Tesla, Snowflake, AMC Entertainment And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
Recent Results Signal Clover Stock Is a Worthy High-Risk Wager
As the situation for Clover Health may not be as bad as once feared, now may be the time to buy hard-hit former meme favorite CLOV stock. 
Via InvestorPlace
Alphabet Stock Remains a Sound Bet for the Future
Alphabet is an industry behemoth and a market leader. The future of GOOGL stock is all but a sure thing, so simply find suitable entries. 
Via InvestorPlace
Surprising Global Optimism Could Help Clover Health Stock Recover
The geopolitical flashpoint is bringing unprecedented global unity, which might indirectly help CLOV stock. 
Via InvestorPlace
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature. 
Via InvestorPlace
88 Biggest Movers From Yesterday
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus... 
Via Benzinga
Global Stocks, Futures Crash; Nasdaq In Bear Market, Oil Soars Above $105 On Russia Attack
U.S. stock index futures crashed along with global markets on Thursday as Russia’s assault on Ukraine sent investors fleeing risky assets, while the tech-heavy Nasdaq was set to open in a bear market. 
Via Talk Markets
Why Clover Health Shares Are Surging After Hours
Clover Health Investments Corp (NASDAQ: CLOV) is ripping higher in Wednesday's after-hours session after the company released its fourth-quarter financial results. ... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc... 
Via Benzinga
Is CLOV Stock a Buy at 52-Week Lows? 3 Analysts Weigh In on Clover Health.
Here's what some expert analysts think about Clover Health and CLOV stock amid the stock's impressive decline to new 52-week lows. 
Via InvestorPlace
7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio
These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold. 
Via InvestorPlace
IPOF Stock Keeps Heating Up as SpaceX SPAC Merger Rumors Persist
After Chamath Palihapitiya stepped down from Virgin Galactic's board, investors are speculating that IPOF stock may merge with SpaceX. 
Via InvestorPlace
Thinking About Buying Stock In Clover Health, Jumia Or Lemonade?
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b... 
Via Benzinga
5 Upcoming SPACs to Watch in 2022
DWAC stock should help reignite the blank-check bubble in 2022. With that in mind, here are some of the best upcoming SPACs to watch. 
Via InvestorPlace
A Buyout May Be the Best Hope for Clover Health Now
The situation behind CLOV stock is spiraling from bad to worse. A sale of the company may be the only option to keep Clover Health running. 
Via InvestorPlace
10 Fintech Stocks To Own Until 2032 and Beyond
While falling out of favor for now, in the long-term the 'digitalization of money' trend could send these 10 fintech stocks higher. 
Via InvestorPlace
SoFi Gets Bank License, But That’s Not Necessarily a Good Thing
A bank chart isn't the solution to SOFI stock's issues 
Via InvestorPlace
CLOV Stock Price Predictions: Why One Analyst See Clover Health Shares Hitting $7
Clover Health Investments (CLOV) stock is on the move Wednesday following a new price prediction from Cowen analyst Gary Taylor. 
Via InvestorPlace
Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Notice: Update in Lawsuit
San Diego, CA -- (SBWIRE) -- 02/02/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Clover Health Investments, Corp.... 
Via SBWire
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million.... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Keybanc lifted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading. 
Via Benzinga
7 Worst SPACs for Smart Investors to Skip in 2022
SPACs may make a comeback in 2022. But some of them won't ever recover. These 7 SPACs have a challenging future ahead of themselves. 
Via InvestorPlace
At Below $3 Clover Health Stock May Be Worth It as a Moonshot
It's unclear whether fortunes will turn around for CLOV stock this year, but among meme plays it may have the most comeback potential. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.